EUVIMEDEUVIMED entdecken
Leserbrief

Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia

Sergio Vano-Galvan iD, David Saceda-Corralo

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.20174 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Sergio Vano-Galvan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hair Disorders Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain. Hauptthemen laut MEDLINE: Alopecia, Dutasteride. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Frontal fibrosing alopecia (FFA) is the most frequent cicatricial alopecia nowadays.The aetiopathogenesis is not completely understood, although a genetic background has been described and potential environmental factors might play a role. 1 Potentially, xenobiotic oestrogens trigger a hormonal imbalance that leads to a chronic autoimmune lymphocytic inflammation against the hair follicle that induce fibrosis and irreversible alopecia.Frontal fibrosing alopecia represents a therapeutic challenge, as there are no double-blind randomized controlled trials (RCTs) supporting a specific therapy.In the last 15 years, several therapies haven been described as potentially

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaDutasterideHumansMaleFemaleAdministration, OralMiddle Aged5-alpha Reductase InhibitorsFibrosisAdultAged

Substanzen

Dutasteride5-alpha Reductase Inhibitors

Autor:innen und Institutionen

  • Hair Disorders Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain.
  • Hair Disorders and Hair Transplantation Unit at Grupo Pedro Jaen Clinic, Madrid, Spain.
  • Secretary General of the European Hair Research Society.

ORCID-Profile: Sergio Vano-Galvan

Zitieren

APA

Vano-Galvan, S., & Saceda-Corralo, D. (2024). Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20174

Vancouver

Vano-Galvan S, Saceda-Corralo D. Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.20174

BibTeX
@article{VanoGalvan2024,
  author = {Vano-Galvan, Sergio and Saceda-Corralo, David},
  title = {Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.20174}
}
Kostenlos starten →